NY State Senate Bill 2023-S6613

Senate Bill S6613

2023-2024 Legislative Session

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations

download bill text pdf

Current Bill Status - In Senate Committee Education Committee

Introduced
- In Committee Assembly
- In Committee Senate
- On Floor Calendar Assembly
- On Floor Calendar Senate
- Passed Assembly
- Passed Senate
Delivered to Governor
Signed By Governor

Please enter your contact information

First Name

Last Name

Email Address

A valid email address is required.

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

View Actions

	Assembly Actions - Lowercase Senate Actions - UPPERCASE
Jan 03, 2024	referred to education
May 01, 2023	referred to education

co-Sponsors

2023-S6613 (ACTIVE) - Details

See Assembly Version of this Bill:: A2114
Current Committee:: Senate Education
Law Section:: Education Law
Laws Affected:: Add §921-b, Ed L
Versions Introduced in 2021-2022 Legislative Session:: A10634

2023-S6613 (ACTIVE) - Summary

Authorizes schools to possess and administer FDA approved opioid reversal agents in emergency situations to negate or neutralize, in whole or in part, the pharmacological effects of an opioid in the human body.

2023-S6613 (ACTIVE) - Sponsor Memo

                                 
BILL NUMBER: S6613

SPONSOR: FERNANDEZ
 
TITLE OF BILL:

An act to amend the education law, in relation to authorizing schools to
possess and administer FDA approved opioid reversal agents in emergency
situations

 
PURPOSE OR GENERAL IDEA OF BILL:

This bill is intended to protect the health and safety of students,
faculty, and family members at various school functions by requiring
school facilities to have opioid reversal agents on premises for use
during emergencies.

 
SUMMARY OF PROVISIONS:

The education law is amended by adding a new section 921-b to read as
described on the bill.

JUSTIFICATION:

Since 2017, the United States Department of Health and Human Services
has declared a public health emergency in response to the national
opioid crisis. Within the first five months of 2022, at least eight K-12
students have overdosed on school grounds in New York. In New York
State, opioid deaths have increased by 44% between 2019 and 2020 alone,
equating to an average of 12 deaths of New Yorkers a day.  Although
being a rampant issue among all ages and demographics, in 2019 there was
an estimated 10.1 million people aged 12 and older misusing opioids.
This means that children as young as 12 are struggling with opioids.

Although opioid use and overdose could be lethal, administration of
naloxone can save lives. Naloxone and other approved agents are opioid
antagonist medications that quickly reverses an overdose by blocking the
effects of opioids. With an incredibly high effectiveness rate, the
medication can be used without any medical training or authorization.
Similar to Louis' Law (which implemented AEDs in schools), having a
lifesaving product in our schools can protect our children against the
dangers of an overdose. This bill does not mandate, but rather strongly
suggests that educational institutions in the state to have opioid
reversal agents on-site for the safety of students and visitors.

 
PRIOR LEGISLATIVE HISTORY:

A. 10634 of the 2021/2022 Legislative Session

 
FISCAL IMPLICATIONS FOR STATE AND LOCAL GOVERNMENTS:

To be determined.

 
EFFECTIVE DATE:
This act shall take effect on the one hundred twentieth day after it
shall have become law.

2023-S6613 (ACTIVE) - Bill Text download pdf

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   6613
 
                        2023-2024 Regular Sessions
 
                             I N  S E N A T E
 
                                May 1, 2023
                                ___________
 
 Introduced by Sen. FERNANDEZ -- read twice and ordered printed, and when
   printed to be committed to the Committee on Education
 
 AN ACT to amend the education law, in relation to authorizing schools to
   possess and administer FDA approved opioid reversal agents in emergen-
   cy situations

   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The education law is amended by adding a new section  921-b
 to read as follows:
   §  921-B.  ON-SITE  FDA  APPROVED  OPIOID REVERSAL AGENTS.   1. SCHOOL
 DISTRICTS, BOARDS OF COOPERATIVE EDUCATIONAL SERVICES, COUNTY VOCATIONAL
 EDUCATION AND EXTENSION BOARDS, CHARTER SCHOOLS, AND NON-PUBLIC  ELEMEN-
 TARY  AND  SECONDARY  SCHOOLS  IN  THIS  STATE  MAY PROVIDE AND MAINTAIN
 ON-SITE IN EACH INSTRUCTIONAL SCHOOL FACILITY ALL  FDA  APPROVED  OPIOID
 REVERSAL  AGENTS  IN QUANTITIES AND TYPES DEEMED BY THE COMMISSIONER, IN
 CONSULTATION WITH THE COMMISSIONER OF HEALTH, TO BE ADEQUATE  TO  ENSURE
 READY  AND  APPROPRIATE ACCESS FOR USE DURING EMERGENCIES TO ANY STUDENT
 OR STAFF TO NEGATE OR NEUTRALIZE, IN WHOLE OR IN PART, THE PHARMACOLOGI-
 CAL EFFECTS OF AN OPIOID IN THE HUMAN BODY.
   2. SCHOOL DISTRICTS, BOARDS OF COOPERATIVE EDUCATIONAL SERVICES, COUN-
 TY VOCATIONAL EDUCATION AND EXTENSION BOARDS, CHARTER SCHOOLS, AND  NON-
 PUBLIC  ELEMENTARY  AND  SECONDARY  SCHOOLS  IN  THIS  STATE, ANY PERSON
 EMPLOYED BY ANY SUCH ENTITY, OR EMPLOYED BY  A  CONTRACTOR  OF  SUCH  AN
 ENTITY  WHILE  PERFORMING SERVICES FOR THE ENTITY MAY ADMINISTER ANY FDA
 APPROVED OPIOID REVERSAL AGENTS IN THE EVENT OF AN EMERGENCY.
   § 2. This act shall take effect on the one hundred twentieth day after
 it shall have become a law. Effective immediately, the addition,  amend-
 ment and/or repeal of any rule or regulation necessary for the implemen-
 tation  of  this act on its effective date are authorized to be made and
 completed on or before such effective date.
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD02445-03-3

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Senate Bill S6613

Share this bill

Sponsored By

Nathalia Fernandez